BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 20137307)

  • 1. [Prophylaxis of graft-versus-host disease in mice by chemical modification of graft and OX40-OX40L costimulatory pathway.].
    Huang YH; Feng SR; DU B; Xu KL; Pan XY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Nov; 30(11):735-40. PubMed ID: 20137307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of pretreatment of allografts with methoxypolyethylene glycol-succinimidyl-propionic acid ester in combination with an anti-OX40L monoclonal antibody in relieving graft-versus-host disease in mice.
    Huang Y; Feng S; Tang R; Du B; Xu K; Pan X
    Int J Hematol; 2010 Nov; 92(4):609-16. PubMed ID: 20953915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of immature dendritic cells genetically modified to express sTNFR I on graft-versus-host disease (GVHD) and graft-versus-leukemia (GVL) in allogeneic bone marrow transplantation mice].
    Wang SH; Li DP; Zhang YJ; Zhang P; Zeng LY; Pan XY; Xu KL; Huang YH
    Zhonghua Xue Ye Xue Za Zhi; 2012 Feb; 33(2):88-93. PubMed ID: 22730654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Study on control of graft-versus-host disease by blocking CD137-CD137L ligand costimulatory pathway in mice].
    Li CH; Xu KL; Pan XY; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2007 Feb; 28(2):93-7. PubMed ID: 17650668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of donors treatment with combination of recombinant human interleukin-11 and recombinant human granulocyte-colony stimulating factor in reduction of incidence of lethal grafts versus host disease after allogeneic bone marrow transplantation].
    Zhao J; Zhao XY; Huang XJ
    Zhonghua Yi Xue Za Zhi; 2005 Sep; 85(35):2497-502. PubMed ID: 16321278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Experimental study of Tripterygium hypoglaucum (level) Hutch on preventing acute graft-versus-host disease in bone marrow transplantation mice].
    Li S; Xu KL; Li ZY; Pan XY; Sun HY; Li DP; Cao J; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):727-30. PubMed ID: 18457261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of relieving graft-versus-host disease by blocking CD137-CD137 ligand costimulatory pathway in vitro.
    Xu K; Li C; Pan X; Du B
    Int J Hematol; 2007 Jul; 86(1):84-90. PubMed ID: 17675273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of immature dendritic cells to express CCR7 on graft-versus-host disease in allogeneic bone marrow transplant mouse model].
    Li DP; Wu JQ; Huang YH; Song LX; Gu HH; Gao CL; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2013 Sep; 34(9):782-7. PubMed ID: 24103877
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Influence of mouse genetic engineering regulatory T cells infusion on post-allogeneic bone marrow transplantation acute graft-versus-host disease in mice].
    Cao J; Li L; Chen C; Zeng LY; Li ZY; Pan XY; Xu KL
    Zhonghua Xue Ye Xue Za Zhi; 2011 Feb; 32(2):83-8. PubMed ID: 21429372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of chemical modification of grafts on the survival improvement post haploidentical bone marrow transplantation in mice].
    Yang G; Tang SQ; Zhang XF; Liu LZ; Huang DS; Wang JW
    Zhonghua Er Ke Za Zhi; 2004 Sep; 42(9):684-7. PubMed ID: 15482672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of third-party tolerogenic dendritic cells in the prevention of acute graft-versus-host-disease following allogeneic bone marrow transplantation in mice].
    Li GP; Yang J; Hao J; Yang YM; Ren YN; Xie RF; Fan HH; Qian KC
    Zhonghua Xue Ye Xue Za Zhi; 2012 Jun; 33(6):461-6. PubMed ID: 22967381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of reducing graft-versus-host disease by in vitro blockade of CD40-CD40 ligand co-stimulatory pathway in allogeneic bone marrow transplantation mouse model].
    Huang SL; Chen C; Duan LN; Li HW; Wen GM; Li L; Zhan MY; Wei J
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jun; 24(6):290-4. PubMed ID: 12859863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prophylaxis of acute graft-versus-host disease after allogeneic bone marrow transplantation by mycophenolate mofetil in a murine model].
    Huang H; Zheng W; Lin M; Fu J; Zhang R
    Zhonghua Xue Ye Xue Za Zhi; 2002 Apr; 23(4):191-3. PubMed ID: 12133455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [An absence of donor TH17 differentiation ameliorates dermal tissue damage].
    Cheng H; Song GL; Pan B; Tian J; Yan ZL; Chen W; Xu KL; Li ZY; Zeng LY
    Zhonghua Yi Xue Za Zhi; 2011 Jul; 91(26):1843-6. PubMed ID: 22093788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Effect of delayed sequential bone marrow transplantation on acute graft-versus-host disease in major H-2 incompatible mouse transplantation].
    Wang CL; Xu KL; Pan XY; Du B
    Zhonghua Xue Ye Xue Za Zhi; 2008 Feb; 29(2):92-6. PubMed ID: 18681308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Simultaneous blockade of costimulatory signals CD28-CD80 and CD40-CD154 combined with monoclonal antibody against CD25 induced a stable chimerism and tolerance without graft-versus-host disease in rat.
    Zhu ZX; Fan LY; Wang Q
    Eur Surg Res; 2011; 46(3):109-17. PubMed ID: 21242693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Role of alloreactive natural killer cell in mouse MHC haploidentical bone marrow transplantation].
    He Y; Wang HH; Wang M; Zhou Z; Zhai WJ; Huang Y; Jiang EL; Wang ZD; Zhou SY; Liu QG; Feng SZ; Han MZ
    Zhonghua Xue Ye Xue Za Zhi; 2006 Feb; 27(2):82-6. PubMed ID: 16732957
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Study on nonmyeloablative allogeneic bone marrow transplantation in the treatment of L615 leukemia mice].
    Xu KL; Ju JP; Pan XY; Du B; Li ZY; Lu QX
    Zhonghua Xue Ye Xue Za Zhi; 2003 Jul; 24(7):372-5. PubMed ID: 12941194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of HGF on GVHD and Th1/Th2-related cytokines in ALL mice after allo-BMT].
    Xia YJ; Gao QP; Wan CC; Cheng FJ; Wang WM; Guo RC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Feb; 13(1):35-8. PubMed ID: 15748432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.
    Asai O; Longo DL; Tian ZG; Hornung RL; Taub DD; Ruscetti FW; Murphy WJ
    J Clin Invest; 1998 May; 101(9):1835-42. PubMed ID: 9576746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.